SignatureFD’s Intersect ENT, Inc XENT Stock Holding History

SignatureFD’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40	Closed	-$1K	–	3451
2022 Q1	$1K	Buy	+40	New	+$1.1K	﹤0.01%	3114
2021 Q4	–	Sell	-38	Closed	-$1K	–	3351
2021 Q3	$1K	Sell	38 -962	-96%	-$23.8K	﹤0.01%	2998
2021 Q2	$17K	Hold	1,000	–	–	﹤0.01%	1792
2021 Q1	$21K	Hold	1,000	–	–	﹤0.01%	1563
2020 Q4	$23K	Hold	1,000	–	–	﹤0.01%	1414
2020 Q3	$16K	Hold	1,000	–	–	﹤0.01%	1479
2020 Q2	$14K	Hold	1,000	–	–	﹤0.01%	1463
2020 Q1	$12K	Hold	1,000	–	–	﹤0.01%	1423
2019 Q4	$25K	Hold	1,000	–	–	﹤0.01%	1201
2019 Q3	$17K	Hold	1,000	–	–	﹤0.01%	1289
2019 Q2	$23K	Hold	1,000	–	–	﹤0.01%	1161
2019 Q1	$32K	Hold	1,000	–	–	﹤0.01%	1017
2018 Q4	$28K	Hold	1,000	–	–	﹤0.01%	1033
2018 Q3	$29K	Hold	1,000	–	–	﹤0.01%	1071
2018 Q2	$37K	Buy	+1,000	New	+$39.3K	﹤0.01%	971
2016 Q4	–	Sell	-236	Closed	-$4K	–	1359
2016 Q3	$4K	Buy	+236	New	+$3.55K	﹤0.01%	1321

SignatureFD's XENT Position: Q2 2022 in Review

SignatureFD sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 40 shares — an estimated $1K sold.

SignatureFD first reported a position in XENT in Q3 2016 and held it in 16 quarters. The position peaked at $37K in Q2 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

SignatureFD reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
SignatureFD sold 40 Intersect ENT, Inc shares in Q2 2022, an estimated $1K.
SignatureFD first reported a position in Intersect ENT, Inc in Q3 2016 and held it in 16 quarters.
SignatureFD's Intersect ENT, Inc position peaked at $37K in Q2 2018.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on SignatureFD's 13F filing for Q2 2022, filed 10 Aug 2022.